Christine E. Thomas - 28 Jan 2025 Form 4 Insider Report for FEMASYS INC (FEMY)

Role
Chief Reg & Clinical Officer
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
Issuer symbol
FEMY
Transactions as of
28 Jan 2025
Net transactions value
$0
Form type
4
Filing time
30 Jan 2025, 19:33:27 UTC
Previous filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FEMY Stock Option (Right to Buy) Award $0 +55,090 $0.000000 55,090 28 Jan 2025 Common Stock 55,090 $1.05 Direct F1
transaction FEMY Stock Option (Right to Buy) Award $0 +28,682 $0.000000 28,682 28 Jan 2025 Common Stock 28,682 $1.05 Direct
transaction FEMY Stock Option (Right to Buy) Award $0 +23,600 $0.000000 23,600 28 Jan 2025 Common Stock 23,600 $1.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
F2 The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.